Vijay Chiruvolu
Chief Tech/Sci/R&D Officer presso TURNSTONE BIOLOGICS CORP.
Profilo
Vijay Chiruvolu is currently the Chief Technology Officer at Turnstone Biologics Corp.
Prior to this, he was the Chief Technical Officer at Instil Bio, Inc. from 2020 to 2022.
He also held the position of Senior Vice President-Process Development at Kite Pharma, Inc. Dr. Chiruvolu holds an MBA from The Pennsylvania State University and a doctorate from The University of Nebraska-Lincoln.
Posizioni attive di Vijay Chiruvolu
| Società | Posizione | Inizio |
|---|---|---|
| TURNSTONE BIOLOGICS CORP. | Chief Tech/Sci/R&D Officer | 01/03/2023 |
Precedenti posizioni note di Vijay Chiruvolu
| Società | Posizione | Fine |
|---|---|---|
| INSTIL BIO, INC. | Chief Tech/Sci/R&D Officer | 02/09/2022 |
| KITE PHARMA INC | Corporate Officer/Principal | - |
Formazione di Vijay Chiruvolu
| The Pennsylvania State University | Masters Business Admin |
| The University of Nebraska-Lincoln | Doctorate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 2 |
|---|---|
| TURNSTONE BIOLOGICS CORP. | Health Technology |
| INSTIL BIO, INC. | Health Technology |
| Aziende private | 1 |
|---|---|
Kite Pharma, Inc.
 Kite Pharma, Inc. BiotechnologyHealth Technology Kite Pharma, Inc. engages in the the development and commercialization of cancer immunotherapy products. Its products include chimeric antigen receptor (CAR) and T cell receptor (TCR), which address both hematological and solid cancers. The company was founded by Arie S. Belldegrun, James S. Economou, and Joshua A. Kazam on 2009 and is headquartered in Santa Monica, CA. | Health Technology |
- Borsa valori
- Insiders
- Vijay Chiruvolu
